<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Psychiatry and Clinical Psychology</title>
<title_fa>مجله روانپزشكي و روانشناسي باليني ايران</title_fa>
<short_title>IJPCP</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijpcp.iums.ac.ir</web_url>
<journal_hbi_system_id>18</journal_hbi_system_id>
<journal_hbi_system_user>journal18</journal_hbi_system_user>
<journal_id_issn>1735-4315</journal_id_issn>
<journal_id_issn_online>2228-7515</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.32598/ijpcp</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>fa</language>
<pubdate>
	<type>jalali</type>
	<year>1382</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2003</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<volume>8</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>fa</language>
	<article_id_doi></article_id_doi>
	<title_fa>مقایسه کارایی ترکیب فلوکستین- هالوپریدول با فلوکستین - دارونما در بیماران اختلال وسواسی- جبری</title_fa>
	<title>Comparison of Efficacy of Fluoxetine-Haloperidol vs. Fluoxetine-Placebo in Obsessive-Compulsive Patients</title>
	<subject_fa>روانپزشکی و روانشناسی</subject_fa>
	<subject>Psychiatry and Psychology</subject>
	<content_type_fa>پژوهشي اصيل</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p class=&quot;2&quot; style=&quot;MARGIN: 18pt 0cm 0pt&quot;&gt;&lt;strong&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;5&quot;&gt;Abstract&lt;/font&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p class=&quot;MsoNormal&quot; style=&quot;MARGIN: 0cm 0cm 0pt DIRECTION: ltr unicode-bidi: embed TEXT-ALIGN: left&quot;&gt;&lt;p&gt;&lt;font face=&quot;Times New Roman&quot; size=&quot;2&quot;&gt; &lt;/font&gt;&lt;/p&gt;&lt;/p&gt;&lt;p class=&quot;a&quot; style=&quot;MARGIN: 1pt 0cm&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;&lt;b&gt;Objectives&lt;/b&gt;: This study was designed to investigate the possibility of dopaminergic involve-ment in obsessive-compulsive patients (OCD). &lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;p class=&quot;a&quot; style=&quot;MARGIN: 1pt 0cm&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;&lt;b&gt;Method:&lt;/b&gt; This double-blind study compared &lt;span style=&quot;LETTER-SPACING: -0.1pt&quot;&gt;the efficacy of fluoxetine-haloperidol with that of &lt;/span&gt;&lt;span style=&quot;LETTER-SPACING: -0.2pt&quot;&gt;fluoxetine-placebo in two groups, each comprised of 12 subjects. These subjects with obsessive-&lt;/span&gt;&lt;span style=&quot;LETTER-SPACING: -0.1pt&quot;&gt;compulsive disorders were selected on the basis of DSM-IV diagnostic criteria they were asse- ssed by a demographic questionnaire and Yale-Brown Scale for evaluating obsessive-compul- &lt;/span&gt;sive disorders.&lt;b&gt; &lt;p&gt;&lt;/p&gt;&lt;/b&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;p class=&quot;a&quot; style=&quot;MARGIN: 1pt 0cm&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;&lt;b&gt;Findings:&lt;/b&gt; The results showed that the response to treatment in haloperidol-fluoxetine group was somewhat better than the fluoxetine-placebo group from the first week of the study. The difference was significant at the third visit (end of fourth week). &lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;p class=&quot;a&quot; style=&quot;MARGIN: 1pt 0cm&quot;&gt;&lt;font size=&quot;3&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;&lt;b&gt;Results:&lt;/b&gt; In addition to serotonin neurotransmitter system, dopaminergic system may play a role in pathophysiology of obsessive-compulsive disorder.&lt;/font&gt;&lt;/font&gt;&lt;span style=&quot;FONT-SIZE: 14pt&quot;&gt;&lt;p&gt;&lt;font face=&quot;Times New Roman&quot;&gt; &lt;/font&gt;&lt;/p&gt;&lt;/span&gt;&lt;/p&gt;</abstract>
	<keyword_fa>وسواسی- اجباری، فلوکستین، هالوپریدول</keyword_fa>
	<keyword>obsessive-compulsive disorder, fluoxetine, haloperidol</keyword>
	<start_page>4</start_page>
	<end_page>10</end_page>
	<web_url>http://ijpcp.iums.ac.ir/browse.php?a_code=A-10-1-202&amp;slc_lang=fa&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Gh.R.</first_name>
	<middle_name></middle_name>
	<last_name>Mirsepasi</last_name>
	<suffix></suffix>
	<first_name_fa>غلامرضا</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>میرسپاسی</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>18003194753284600768</code>
	<orcid>18003194753284600768</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>A.</first_name>
	<middle_name></middle_name>
	<last_name>Saliani</last_name>
	<suffix></suffix>
	<first_name_fa>انوشه</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>سالیانی</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>E-mail: drsaliani@mail.com</email>
	<code>18003194753284600769</code>
	<orcid>18003194753284600769</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
